Works matching IS 15272729 AND DT 2022 AND VI 23 AND IP 3
Results: 10
Additive Processing of a X22CrMoV12-1 Steel: Structure, Properties and Product.
- Published in:
- Current Treatment Options in Oncology, 2022, v. 23, n. 3, p. 283, doi. 10.1007/s41403-020-00191-x
- By:
- Publication type:
- Article
Novel Aeroelastic Approaches for Transonic Flutter and Buffet Clearance of Aerospace Vehicles.
- Published in:
- Current Treatment Options in Oncology, 2022, v. 23, n. 3, p. 243, doi. 10.1007/s41403-020-00190-y
- By:
- Publication type:
- Article
Development of Turbopump Systems for Cryogenic and Semicryogenic Propulsion Systems of ISRO.
- Published in:
- Current Treatment Options in Oncology, 2022, v. 23, n. 3, p. 229, doi. 10.1007/s41403-020-00189-5
- By:
- Publication type:
- Article
Engineering/Technology Talent Development on the College Campus.
- Published in:
- Current Treatment Options in Oncology, 2022, v. 23, n. 3, p. 219, doi. 10.1007/s41403-020-00188-6
- By:
- Publication type:
- Article
Thanks to reviewers 2021.
- Published in:
- Current Treatment Options in Oncology, 2022, v. 23, n. 3, p. 605, doi. 10.1007/s12094-022-02789-9
- Publication type:
- Article
Identification of a novel cancer microbiome signature for predicting prognosis of human breast cancer patients.
- Published in:
- Current Treatment Options in Oncology, 2022, v. 23, n. 3, p. 597, doi. 10.1007/s12094-021-02725-3
- By:
- Publication type:
- Article
PD1/PDL1 expression is associated with increased TIM3 expression and tumor-infiltrating T lymphocytes in fibroblastic tumors.
- Published in:
- Current Treatment Options in Oncology, 2022, v. 23, n. 3, p. 586, doi. 10.1007/s12094-021-02723-5
- By:
- Publication type:
- Article
High-dose-rate plesiotherapy with customized molds in non-melanoma skin cancer: efficacy and safety at 10 years—single institution experience.
- Published in:
- Current Treatment Options in Oncology, 2022, v. 23, n. 3, p. 578, doi. 10.1007/s12094-021-02718-2
- By:
- Publication type:
- Article
Expressions of PD-L1 and Nectin-4 in urothelial cancer patients treated with pembrolizumab.
- Published in:
- Current Treatment Options in Oncology, 2022, v. 23, n. 3, p. 568, doi. 10.1007/s12094-021-02717-3
- By:
- Publication type:
- Article
Measures to evaluate quality of care in renal cancer: results of a Delphi study in Spain.
- Published in:
- Current Treatment Options in Oncology, 2022, v. 23, n. 3, p. 495, doi. 10.1007/s12094-021-02703-9
- By:
- Publication type:
- Article